Korean J Pediatr.
2019 Jun;62(6):224-234. 10.3345/kjp.2018.06968.
Clinical and molecular characterization of Korean children with infantile and late-onset Pompe disease: 10 years of experience with enzyme replacement therapy at a single center
- Affiliations
-
- 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. nadri1217@naver.com
- 2Department of Pediatrics, Inha University College of Medicine, Incheon, Korea.
- 3Department of Pediatrics, Hanyang University College of Medicine, Seoul, Korea.
- 4Department of Pediatrics, Samsung Medical Center, Seoul, Korea.
- 5Samsung Biomedical Research Institute, Seoul, Korea.
- 6Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- KMID: 2452034
- DOI: http://doi.org/10.3345/kjp.2018.06968
Abstract
- PURPOSE
Pompe disease (PD) is an autosomal recessive disorder caused by a deficiency of acid alpha-glucosidase resulting from pathogenic GAA variants. This study describes the clinical features, genotypes, changes before and after enzyme replacement therapy (ERT), and long-term outcomes in patients with infantile-onset PD (IOPD) and late-onset PD (LOPD) at a tertiary medical center.
METHODS
The medical records of 5 Korean patients (2 male, 3 female patients) diagnosed with PD between 2002 and 2013 at Samsung Medical Center in Seoul, Republic of Korea were retrospectively reviewed for data, including clinical and genetic characteristics at diagnosis and clinical course after ERT.
RESULTS
Common initial symptoms included hypotonia, cyanosis, and tachycardia in patients with IOPD and limb girdle weakness in patients with LOPD. Electrocardiography at diagnosis revealed hypertrophic cardiomyopathy in all patients with IOPD who showed a stable disease course during a median follow-up period of 10 years. Patients with LOPD showed improved hepatomegaly and liver transaminase level after ERT.
CONCLUSION
As ERT is effective for treatment of PD, early identification of this disease is very important. Thus, patients with IOPD should be considered candidates for clinical trials of new drugs in the future.
MeSH Terms
-
alpha-Glucosidases
Cardiomyopathy, Hypertrophic
Child*
Cyanosis
Diagnosis
Electrocardiography
Enzyme Replacement Therapy*
Extremities
Female
Follow-Up Studies
Genotype
Glycogen Storage Disease Type II*
Hepatomegaly
Humans
Liver
Male
Medical Records
Muscle Hypotonia
Republic of Korea
Retrospective Studies
Seoul
Tachycardia
alpha-Glucosidases
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical improvement in a case of atypical infantile onset Pompe disease with enzyme replacement therapy
- General Anesthesia in a Patient with Infantile Pompe's Disease : A case report
- Clinical Characteristics of Childhood Pompe Disease
- Considerations for evaluating the effectiveness and long-term outcome of enzyme replacement therapy in Pompe disease
- Two Patients with Atypical Infantile Pompe Disease Presenting with Hypertrophic Cardiomyopathy
